Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
78.85
Change Change %
5.30 7.21%

Updated:27 Jan, 2021, 10:04 AM IST

BSE
78.60
Change Change %
4.50 6.07%

Updated:27 Jan, 2021, 10:16 AM IST

Jagsonpal Pharma's Latest News

Jagsonpal Pharma's Recent video coverage

Jagsonpal Pharma's Announcements

AGM

AGM

By NSE on 16 Aug 2018 | 00:00 AM

/Book Closure

Updates

Updates

By NSE on 16 Aug 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from...

Reply to Clarification- Financial results

Reply to Clarification- Financial results

By NSE on 18 Jun 2018 | 00:00 AM

The Exchange had sought clarification from Jagsonpal Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing ...

Dividend

Dividend

By NSE on 30 May 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 30, 2018, recommended Final Dividend @ ...

Financial Result Updates

Financial Result Updates

By NSE on 30 May 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Outcome of Board Meeting

Outcome of Board Meeting

By NSE on 30 May 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2018.

Updates

Updates

By NSE on 26 Apr 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Dear Sir/Madam,Please find enclosed copies of the notice given to the sharehold...

Disc. under Reg.30 of SEBI (SAST) Reg.2011

Disc. under Reg.30 of SEBI (SAST) Reg.2011

By NSE on 11 Apr 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition...

Disc. under Reg.30 of SEBI (SAST) Reg.2011

Disc. under Reg.30 of SEBI (SAST) Reg.2011

By NSE on 03 Apr 2018 | 00:00 AM

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition...

Top
Listen to the latest songs, only on JioSaavn.com